PATENT CLAIM ANALYSIS

Application Number: 15886659
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["424", "468000"]

Abstract:
Opioid controlled release formulation resistant to alcohol extraction of the opioid.

Claim (Index 93):
A controlled release dosage form comprising a plurality of matrices comprising a therapeutically effective amount of a pharmaceutically acceptable salt of hydromorphone dispersed in a controlled release material;\n wherein the ratio of the amount of the pharmaceutically acceptable salt of hydromorphone released after 1 hour of in-vitro dissolution of the dosage form in 500 ml of Simulated Gastric Fluid with 20% ethanol using a USP Apparatus I (basket) apparatus at 100 rpm at 37 degrees C.\u00b0 to the amount of a pharmaceutically acceptable salt of hydromorphone released after 1 hour of in-vitro dissolution of the dosage form in 500 ml of Simulated Gastric Fluid with 0% ethanol using a USP Apparatus I (basket) apparatus at 100 rpm at 37 degrees C.\u00b0 is less than about 2:1.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 88.0
- Lexical Diversity: 1.0
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13900873', '13333560', '13901218', '14040535', '15245338']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6802614455646551
- 35 USC 102 Novelty (BERT): 0.5525396252302233
- Combined Prediction Score: 0.6674892635312119
- Mean Citation Score: 395.594268
- Max Citation Score: 406.89218
- Similarity Product: 336.88320364246965

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test